Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-03-12 @ 1:05 AM
Study NCT ID:
NCT05660720
Status:
UNKNOWN
Last Update Posted:
2022-12-21
First Post:
2022-11-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-11
First Submit QC Date:
None
Study First Post Date:
2022-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-19
Last Update Post Date:
2022-12-21
Last Update Post Date Type:
ACTUAL